Sonoma Pharmaceuticals, Inc. (SNOA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue TTM

0 8M 16M 24M Q4 '11: 9.8M Q1 '12: 10.4M Q2 '12: 11.6M Q3 '12: 12.1M Q4 '12: 12.7M Q1 '13: 13.9M Q2 '13: 14.7M Q3 '13: 15.5M Q4 '13: 15.5M Q1 '14: 14.8M Q2 '14: 14.3M Q3 '14: 14.1M Q4 '14: 13.7M Q1 '15: 13.7M Q2 '15: 12.9M Q3 '15: 12.8M Q4 '15: 13.9M Q1 '16: 14.1M Q2 '16: 14.9M Q3 '16: 14.2M Q4 '16: 12.8M Q1 '17: 11.8M Q2 '17: 10.5M Q3 '17: 11.4M Q4 '17: 12.8M Q1 '18: 14M Q2 '18: 15.6M Q3 '18: 17M Q4 '18: 16.7M Q1 '19: 17.2M Q2 '19: 17.8M Q3 '19: 18.2M Q4 '19: 19M Q1 '20: 19.3M Q2 '20: 19.3M Q3 '20: 18.7M Q4 '20: 18.7M Q1 '21: 19.7M Q2 '21: 20.5M Q3 '21: 20.8M Q4 '21: 18.6M Q1 '22: 16.5M Q2 '22: 14.5M Q3 '22: 12.5M Q4 '22: 12.6M Q1 '23: 12.9M Q2 '23: 12.5M Q3 '23: 12.6M Q4 '23: 13.3M Q1 '24: 12.7M Q2 '24: 12.1M Q3 '24: 12.3M Q4 '24: 12.7M Q1 '25: 12.7M Q2 '25: 13.5M Q3 '25: 14M Q4 '25: 14.3M Q1 '26: 14.9M Q2 '26: 16.9M Q3 '26: 17.7M Q4 '26: 19.5M Q1 '27: 21.9M Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Gross Profit TTM

0 4M 8M 12M Q4 '11: 6.1M Q1 '12: 6.7M Q2 '12: 7.8M Q3 '12: 8.5M Q4 '12: 8.7M Q1 '13: 9.6M Q2 '13: 10.1M Q3 '13: 10.7M Q4 '13: 10.7M Q1 '14: 10.1M Q2 '14: 9.6M Q3 '14: 9.2M Q4 '14: 8.4M Q1 '15: 8.1M Q2 '15: 7.1M Q3 '15: 6.7M Q4 '15: 7.3M Q1 '16: 7.3M Q2 '16: 7.6M Q3 '16: 6.4M Q4 '17: 5.7M Q1 '18: 6.5M Q2 '18: 7.3M Q3 '18: 7.9M Q4 '18: 7.3M Q1 '19: 7.3M Q2 '19: 7.9M Q3 '19: 8.3M Q4 '19: 8.9M Q1 '20: 9.4M Q2 '20: 9.2M Q3 '20: 8.3M Q4 '20: 8.1M Q1 '21: 8.1M Q2 '21: 8.4M Q3 '21: 8.4M Q4 '21: 6.6M Q1 '22: 5.8M Q2 '22: 4.5M Q3 '22: 3.7M Q4 '22: 4M Q1 '23: 4.2M Q2 '23: 4.5M Q3 '23: 4.1M Q4 '23: 4.9M Q1 '24: 4.4M Q2 '24: 3.9M Q3 '24: 4.5M Q4 '24: 4.7M Q1 '25: 4.8M Q2 '25: 5.2M Q3 '25: 5M Q4 '25: 5.5M Q1 '26: 5.6M Q2 '26: 6.4M Q3 '26: 6.8M Q4 '26: 7.4M Q1 '27: 8.5M Q1 '12 Q1 '14 Q1 '16 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q4 '11: -7.5M Q1 '12: -7.1M Q2 '12: -6.1M Q3 '12: -6.4M Q4 '12: -6.5M Q1 '13: -4.9M Q2 '13: -5.1M Q3 '13: -3.5M Q4 '13: -3.4M Q1 '14: -4M Q2 '14: -4.5M Q3 '14: -5.3M Q4 '14: -6.1M Q1 '15: -6.4M Q2 '15: -6.7M Q3 '15: -7.1M Q4 '15: -6.7M Q1 '16: -7.5M Q2 '16: -7.8M Q3 '16: -10M Q4 '16: -12M Q1 '17: -13.2M Q2 '17: -14.3M Q3 '17: -13.7M Q4 '17: -13M Q1 '18: -12.8M Q2 '18: -12.7M Q3 '18: -12.4M Q4 '18: -14.2M Q1 '19: -14.4M Q2 '19: -14.2M Q3 '19: -13.3M Q4 '19: -11.3M Q1 '20: -9.5M Q2 '20: -8.1M Q3 '20: -6.9M Q4 '20: -7.4M Q1 '21: -6.3M Q2 '21: -4.8M Q3 '21: -3.9M Q4 '21: -3.4M Q1 '22: -3.7M Q2 '22: -4.8M Q3 '22: -5.6M Q4 '22: -5.9M Q1 '23: -5.8M Q2 '23: -5.6M Q3 '23: -6.5M Q4 '23: -4.6M Q1 '24: -5M Q2 '24: -5.4M Q3 '24: -4.4M Q4 '24: -4.7M Q1 '25: -4.6M Q2 '25: -4.3M Q3 '25: -4.5M Q4 '25: -3.7M Q1 '26: -3.6M Q2 '26: -3.1M Q3 '26: -2.8M Q4 '26: -2.5M Q1 '27: -1.4M Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q4 '11: -7.9M Q1 '12: -7.7M Q2 '12: -6.9M Q3 '12: -7.3M Q4 '12: -7.3M Q1 '13: -4.7M Q2 '13: -5.4M Q3 '13: -4.8M Q4 '13: -5.4M Q1 '14: -7.6M Q2 '14: -7.5M Q3 '14: -6.2M Q4 '14: 3.7M Q1 '15: 5.4M Q2 '15: 6.1M Q3 '15: 755K Q4 '15: -8.2M Q1 '16: -10.5M Q2 '16: -11.5M Q3 '16: -8.8M Q4 '16: -10.2M Q1 '17: -10.4M Q2 '17: -10.6M Q3 '17: 8.8M Q4 '17: 9.3M Q1 '18: 8.3M Q2 '18: 7.4M Q3 '18: -12M Q4 '18: -14.3M Q1 '19: -14.3M Q2 '19: -14.2M Q3 '19: -13.3M Q4 '19: -11.8M Q1 '20: -7.6M Q2 '20: -6M Q3 '20: -4.8M Q4 '20: -3.3M Q1 '21: -3.8M Q2 '21: -2.5M Q3 '21: -2M Q4 '21: -4M Q1 '22: -5.3M Q2 '22: -5.5M Q3 '22: -5.8M Q4 '22: -5.1M Q1 '23: -4.9M Q2 '23: -5.8M Q3 '23: -6.8M Q4 '23: -5.2M Q1 '24: -5.7M Q2 '24: -6.1M Q3 '24: -5.1M Q4 '24: -4.8M Q1 '25: -4.6M Q2 '25: -3.7M Q3 '25: -3.7M Q4 '25: -3.5M Q1 '26: -3.6M Q2 '26: -3.5M Q3 '26: -3.4M Q4 '26: -3.2M Q1 '27: -2.3M Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Cost of Revenue TTM

0 5M 10M 15M Q4 '11: 3.6M Q1 '12: 2.8M Q2 '12: 2.9M Q3 '12: 2.6M Q4 '12: 3.1M Q1 '13: 3.1M Q2 '13: 3.5M Q3 '13: 3.6M Q4 '13: 3.6M Q1 '14: 4.7M Q2 '14: 4.8M Q3 '14: 4.9M Q4 '14: 5.3M Q1 '15: 5.6M Q2 '15: 5.7M Q3 '15: 6.1M Q4 '15: 6.6M Q1 '16: 6.9M Q2 '16: 7.3M Q3 '16: 7.8M Q4 '16: 7.4M Q1 '17: 7.3M Q2 '17: 7.1M Q3 '17: 6.7M Q4 '17: 7.2M Q1 '18: 7.6M Q2 '18: 8.3M Q3 '18: 9.1M Q4 '18: 9.3M Q1 '19: 9.9M Q2 '19: 9.9M Q3 '19: 9.9M Q4 '19: 10.1M Q1 '20: 9.7M Q2 '20: 9.7M Q3 '20: 9.7M Q4 '20: 9.8M Q1 '21: 11.1M Q2 '21: 11.8M Q3 '21: 12.4M Q4 '21: 12.1M Q1 '22: 10.8M Q2 '22: 10M Q3 '22: 8.8M Q4 '22: 8.6M Q1 '23: 8.7M Q2 '23: 8M Q3 '23: 8.4M Q4 '23: 8.4M Q1 '24: 8.3M Q2 '24: 8.2M Q3 '24: 7.8M Q4 '24: 8M Q1 '25: 7.9M Q2 '25: 8.3M Q3 '25: 8.9M Q4 '25: 8.8M Q1 '26: 9.3M Q2 '26: 10.6M Q3 '26: 11M Q4 '26: 12.1M Q1 '27: 13.4M Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Operating Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '11: -4.4M Q1 '12: -3.5M Q2 '12: -3.2M Q3 '12: -2.8M Q4 '12: -4M Q1 '13: -4.8M Q2 '13: 728K Q3 '13: 880K Q4 '13: 1.1M Q1 '14: 1.4M Q2 '14: -4.6M Q3 '14: -4.4M Q4 '14: -4.9M Q1 '15: -5.2M Q2 '15: -5.4M Q3 '15: -5.6M Q4 '15: -6.7M Q1 '16: -7.9M Q2 '16: -8M Q3 '16: -9.7M Q4 '16: -8.7M Q1 '17: -8.5M Q2 '17: -8.4M Q3 '17: -7.2M Q4 '17: -8.2M Q1 '18: -10.4M Q2 '18: -11.4M Q3 '18: -12.1M Q4 '18: -12.4M Q1 '19: -10.9M Q2 '19: -11.8M Q3 '19: -12M Q4 '19: -11.7M Q1 '20: -7.9M Q2 '20: -5.3M Q3 '20: -3.7M Q4 '20: -4.6M Q1 '21: -7.6M Q2 '21: -7.1M Q3 '21: -5.5M Q4 '21: -3.4M Q1 '22: -2.3M Q2 '22: -3.3M Q3 '22: -4.3M Q4 '22: -4.2M Q1 '23: -4.6M Q2 '23: -5.1M Q3 '23: -5.1M Q4 '23: -6.2M Q1 '24: -4.8M Q2 '24: -4.2M Q3 '24: -5M Q4 '24: -2.4M Q1 '25: -3.1M Q2 '25: -1.5M Q3 '25: 159K Q4 '25: -88K Q1 '26: -1.2M Q2 '26: -2.2M Q3 '26: -3.5M Q4 '26: -3.9M Q1 '27: -2.6M Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '21 Q1 '23 Q1 '25 Q1 '27

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q4 '11: -4.6M Q1 '12: -3.7M Q2 '12: -3.4M Q3 '12: -3M Q4 '12: -4.4M Q1 '13: -5M Q2 '13: 432K Q3 '13: 494K Q4 '13: 893K Q1 '14: 916K Q2 '14: -5.1M Q3 '14: -5M Q4 '14: -5.4M Q1 '15: -5.5M Q2 '15: -5.6M Q3 '15: -5.7M Q4 '15: -6.8M Q1 '16: -8.2M Q2 '16: -8.4M Q3 '16: -10.1M Q4 '16: -9.1M Q1 '17: -8.7M Q2 '17: -8.6M Q3 '17: -7.4M Q4 '17: -8.6M Q1 '18: -11M Q2 '18: -11.9M Q3 '18: -12.5M Q4 '18: -12.6M Q1 '19: -10.9M Q2 '19: -11.9M Q3 '19: -12.1M Q4 '19: -11.8M Q1 '20: -8M Q2 '20: -5.4M Q3 '20: -3.8M Q4 '20: -4.8M Q1 '21: -7.9M Q2 '21: -7.3M Q3 '21: -5.8M Q4 '21: -3.6M Q1 '22: -2.5M Q2 '22: -3.4M Q3 '22: -4.4M Q4 '22: -4.4M Q1 '23: -4.7M Q2 '23: -5.2M Q3 '23: -5.2M Q4 '23: -6.4M Q1 '24: -5.1M Q2 '24: -4.5M Q3 '24: -5.2M Q4 '25: -168K Q1 '26: -1.4M Q2 '26: -2.3M Q3 '26: -3.7M Q4 '26: -4.1M Q1 '27: -2.7M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q3 '11: 26.4M Q3 '12: 27M Q3 '16: 3.3M Q3 '17: 4.2M Q3 '18: 4.4M Q1 '19: 693K Q1 '20: 1.3M Q2 '20: 1.3M Q1 '21: 1.8M Q2 '21: 2.2M Q3 '21: 2.1K Q1 '22: 2.1M Q2 '22: 2.3K Q3 '22: 3.1K Q1 '23: 3.1K Q2 '23: 3.1K Q3 '23: 3.1M Q1 '24: 4.9M Q2 '24: 258K Q3 '24: 546K Q1 '25: 851K Q2 '25: 1M Q3 '25: 1.5M Q1 '26: 1.6M Q2 '26: 1.6M Q3 '26: 1.7M Q1 '27: 3.8M Q3 '16 Q1 '20 Q3 '21 Q1 '23 Q2 '24 Q3 '25 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '11: -0.29 Q1 '12: -0.28 Q2 '12: -0.25 Q3 '12: -0.26 Q4 '12: -1.86 Q1 '13: -1.92 Q2 '13: -2.22 Q3 '13: -2.50 Q4 '13: -1.29 Q1 '14: -1.41 Q2 '14: -1.29 Q3 '14: -1.01 Q4 '15: -0.84 Q1 '16: -1.60 Q2 '16: -2.06 Q3 '16: -2.33 Q4 '16: -4.91 Q1 '17: -4.75 Q2 '17: -4.67 Q3 '17: 0.13 Q4 '17: 2.20 Q1 '18: 1.99 Q2 '18: 1.78 Q3 '18: -2.79 Q4 '19: -13.27 Q1 '20: -7.74 Q2 '20: -4.73 Q3 '20: -3.08 Q4 '20: -2.20 Q1 '21: -2.61 Q2 '21: -1.63 Q2 '24: -6.94 Q3 '24: -7.91 Q4 '24: -10.63 Q1 '25: -11.68 Q2 '25: -6.52 Q3 '25: -5.56 Q4 '25: -2.95 Q1 '26: -2.37 Q2 '26: -2.10 Q3 '26: -1.95 Q4 '26: -1.89 Q1 '27: -1.22 Q4 '11 Q2 '13 Q4 '15 Q2 '17 Q4 '19 Q2 '21 Q3 '25 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.